Auch in der Corona-Krise ist die Schreiner Group weiterhin für Sie da

Liebe Kunden, Lieferanten, Partner und Mitarbeiter,

die derzeitige Corona-Krise stellt uns alle vor große Herausforderungen. In der momentanen Ausnahmesituation hat die Schreiner Group zwei große Ziele, an denen die gesamte Belegschaft intensiv und engagiert arbeitet: der Schutz der Menschen und die Aufrechterhaltung der Lieferfähigkeit.

Lesen Sie die vollständige Stellungnahme unserer Geschäftsführung


Schreiner Group continues to stand by your side also during the corona crisis

Dear customers, suppliers, partners and employees,

The current corona crisis confronts all of us with great challenges. In the present emergency situation, Schreiner Group has two major aims that our entire workforce is pursuing with intensity and dedication: protecting people and sustaining our ability to supply our products.

Read the full statement issued by our CEO

Our Business Unit Schreiner MediPharm

Schreiner MediPharm Products

Product Life Cycle Management Overview

Product Life Cycle Management

  • Product Development and Brand Management Support

    Innovative pharmaceutical companies invest a lot of resources and time in clinical trials. At the same time, expiring patents and growing competitive intensity pose major challenges to the pharmaceutical industry. Therefore, the successful launch of innovative products is all the more important. Schreiner MediPharm offers solutions for every stage in a product’s lifecycle.

    • CTS Solutions (Clinical Trial Supplies)

      Booklet-Labels and special blinding solutions for international clinical trials ensure flexible and safe processes.

    • Customized Solutions

      Tailored solutions are customized to the respective product and perform additional functions. Thanks to Schreiner MediPharm’s development expertise and innovative product features, solutions are created that enhance and differentiate the final product from the competition.